The global treatment market for Duchenne Muscular Dystrophy (DMD) will expand in value at a staggering Compound Annual Growth Rate (CAGR) of 160.5%, from approximately $8.2 million in 2014 to $990 million by 2019.
Reportstack’s latest report "OpportunityAnalyzer: Duchenne Muscular Dystrophy-Opportunity and Market Analysis to 2019" states that...
More...




